Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Chemmedchem
|
July 15, 2011
From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease
Markus Geissen, Fabienne Leidel, Martin Eiden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2007
Light-triggered beta-hairpin folding and unfolding
Tobias E Schrader, Wolfgang J Schreier, Thorben Cordes, et al.
European Biophysics Journal : EBJ
|
September 29, 2004
A new method to determine the structure of the metal environment in metalloproteins: investigation of the prion protein octapeptide repeat Cu(2+) complex
Matthias Mentler, Andreas Weiss, Klaus Grantner, et al.
Acta Neuropathologica
|
April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Chemmedchem
|
July 15, 2011
From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease
Markus Geissen, Fabienne Leidel, Martin Eiden, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 26, 2007
Light-triggered beta-hairpin folding and unfolding
Tobias E Schrader, Wolfgang J Schreier, Thorben Cordes, et al.
European Biophysics Journal : EBJ
|
September 29, 2004
A new method to determine the structure of the metal environment in metalloproteins: investigation of the prion protein octapeptide repeat Cu(2+) complex
Matthias Mentler, Andreas Weiss, Klaus Grantner, et al.
Acta Neuropathologica
|
April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Page
of 5